Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease.

MLA

Mortazavi, Negar, et al. “Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease.” Iranian Journal of Pharmaceutical Research, vol. 16, no. 4, Sept. 2017, pp. 1639–47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=126446863&authtype=sso&custid=ns315887.

APA

Mortazavi, N., Esmaeilzadeh, H., Abbasinazari, M., Babaie, D., Alyasin, S., Nabavizadeh, H., & Esmailzadeh, E. (2017). Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease. Iranian Journal of Pharmaceutical Research, 16(4), 1639–1647.

Chicago

Mortazavi, Negar, Hossein Esmaeilzadeh, Mohammad Abbasinazari, Delara Babaie, Soheila Alyasin, Hesamodin Nabavizadeh, and Elmira Esmailzadeh. 2017. “Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease.” Iranian Journal of Pharmaceutical Research 16 (4): 1639–47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=126446863&authtype=sso&custid=ns315887.